Viewing Study NCT02334527


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-03-25 @ 3:35 PM
Study NCT ID: NCT02334527
Status: TERMINATED
Last Update Posted: 2018-11-16
First Post: 2015-01-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LCCC 1406
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View